The mature Japanese CRM device market will remain flat through 2026, characterized by low generator unit volume growth, rising ICM procedure volumes, and price erosion. The uptake of premium-priced devices such as CRT devices, leadless pacemakers, and S-ICDs will help mitigate the downward pressure of reimbursement cuts over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the Japanese cardiac rhythm management device market across a 10-year period.


Adoption of novel devices will offset waning revenue for traditional devices in the Japanese CRM market.

What is the predicted uptake of novel devices such as leadless pacemakers and S-ICDs? Will leadless pacemakers and S-ICDs become the standard of care?

To what extent does the uptake of leadless pacemakers like Medtronic's Micra and Boston Scientific's EMBLEM S-ICDs offset declining revenue in other markets?

New-generation miniature ICMs like Medtronic's Reveal LINQ have experienced strong uptake, how does this affect competitive standings? Have other ICM competitors met Medtronic's challenge? How does the availability of this device affect sales of other CRM devices?

The mature CRM device market will remain highly saturated, which leads competitors to find innovations to achieve growth.

How do epidemiological trends and new technology influence growth in different pulse generator product segments? How are these trends different compared to the rapidly expanding ICM market?

How can individual competitors realize growth in this large but fairly mature market?

The MHLW's biennial reimbursement revisions are having a significant impact on pricing trends.

How are the MHLW's biennial reimbursement revisions different between device segments? What 2018 revisions will affect market growth?

How are the ASP trends for novel devices different compared to those for more established devices?

Table of contents

  • Japan
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Key Report Updates
      • Procedures Covered
      • Products Covered
    • Version History
    • Cardiac Rhythm Management Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
        • Clinical Data
        • Product Portfolio Management
        • Negative Press
        • Mergers, Acquisitions, and Partnerships
        • First-Mover Advantage
        • Regulatory Environment
      • Market Developments
    • Pacemaker Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Implantable Cardioverter Defibrillator Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Cardiac Resynchronization Therapy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Mergers, Acquisitions, and Partnerships
    • Lead Market
      • Market Definitions
      • Market Forecast Data
      • Market Shares
    • Lead Extraction Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Insertable Cardiac Monitor Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Erik J. Bracciodieta, MBiotech

Erik J. Bracciodieta is a senior analyst within the Cardiovascular Medtech Insights team, specializing in cardiac rhythm management and structural heart closure device markets, as well as medical device pricing and regulations in Japan. Erik holds a Master's degree in Biotechnology from the University of Toronto. Follow Erik on Twitter: @ErikB_DRG.  


Related Reports

Cardiac Rhythm Management Devices | Medtech 360 | Market Insights | Latin America (Supplemental)

The Latin American market for CRM devices will experience modest growth through 2026, driven primarily by an aging population, the i...

View Details

Cardiac Rhythm Management Devices | Medtech 360 | Market Insights | Asia Pacific (Supplemental)

The Asia Pacific market for CRM devices will expand through 2026, driven primarily by an aging population, th...

View Details

Cardiac Rhythm Management Devices | Medtech 360 | Market Insights | United States

The mature US CRM device market will remain flat through 2026, striking a balance between flat generator unit sales, rising...

View Details

Cardiac Rhythm Management Devices | Medtech 360 | Market Insights | Asia Pacific

The Asia Pacific market for CRM devices will expand through 2026, driven primarily by an aging population, the inc...

View Details